2014 Opportunities in the Global Enteric Diseases Diagnostic Testing Market
NEW YORK, Dec. 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
2014 Opportunities in the Global Enteric Diseases Diagnostic Testing Market
http://www.reportlinker.com/p01923220/2014-Opportunities-in-the-Global-Enteric-Diseases-Diagnostic-Testing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
This new 389-page report from Venture Planning Group contains 97 tables and provides analysis of the global enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
About this Report
Europe France Germany Italy Spain Japan Campylobacter Cryptosporidium E. Coli, Enterovirus Rhinovirus Rotavirus Salmonella Shigella Vibrio Yersinia- Hospitals- Commercial/Private Labs- Physician Offices- Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by test and country. Also, the report:
- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used
for enteric disease testing;
- Profiles key suppliers and potential market entrants developing innovativetechnologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.
Methodology
JapanIn addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group's proprietary data files was conducted.
Contains 389 pages and 97 tables
I. IntroductionII. Worldwide Market and Technology OverviewA. Major Infectious Disease Tests
1. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Cryptosporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Yersinia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares
V. Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares
IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio/Innogenetics
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako
List of Tables
Major Companies Developing or Marketing Campylobacter TestsMajor Companies Developing or Marketing Enterovirus TestsMajor Companies Developing or Marketing Rotavirus TestsMajor Companies Developing or Marketing Salmonella TestsMajor Companies Developing or Marketing Shigella TestsMajor Companies Developing or Marketing Yersinia TestsFranceCampylobacter Test Volume and Diagnostics Sales Forecast by Market SegmentFranceCampylobacter Diagnostics Sales by Major SupplierFranceCryptosporidium Test Volume and Diagnostics Sales Forecast by Market SegmentFranceCryptosporidium Diagnostics Sales by Major SupplierFranceE. Coli Test Volume and Diagnostics Sales Forecast by Market SegmentFranceEnterovirus Test Volume and Diagnostics Sales Forecast by Market SegmentFranceRhinovirus Test Volume and Diagnostics Sales Forecast by Market SegmentFranceRotavirus Test Volume and Diagnostics Sales Forecast by Market SegmentFranceRotavirus Testing Market Diagnostics Sales by Major SupplierFranceSalmonella Test Volume and Diagnostics Sales Forecast by Market SegmentFranceShigella Test Volume and Diagnostics Sales Forecast by Market SegmentFranceShigella Testing Market Diagnostics Sales by Major SupplierFranceVibrio Test Volume and Diagnostics Sales Forecast by Market SegmentFranceYersinia Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyCampylobacter Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyCampylobacter Diagnostics Sales by Major SupplierGermanyCryptosporidium Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyCryptosporidium Diagnostics Sales by Major SupplierGermanyE. Coli Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyEnterovirus Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyRhinovirus Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyRotavirus Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyRotavirus Testing Market Diagnostics Sales by Major SupplierGermanySalmonella Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyShigella Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyVibrio Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyYersinia Test Volume and Diagnostics Sales Forecast by Market SegmentItalyCampylobacter Test Volume and Diagnostics Sales Forecast by Market SegmentItalyCampylobacter Diagnostics Sales by Major SupplierItalyCryptosporidium Test Volume and Diagnostics Sales Forecast by Market SegmentItalyCryptosporidium Diagnostics Sales by Major SupplierItalyE. Coli Test Volume and Diagnostics Sales Forecast by Market SegmentItalyEnterovirus Test Volume and Diagnostics Sales Forecast by Market SegmentItalyRhinovirus Test Volume and Diagnostics Sales Forecast by Market SegmentItalyRotavirus Test Volume and Diagnostics Sales Forecast by Market SegmentItalyRotavirus Testing Market Diagnostics Sales by Major SupplierItalySalmonella Test Volume and Diagnostics Sales Forecast by Market SegmentItalyShigella Test Volume and Diagnostics Sales Forecast by Market SegmentItalyVibrio Test Volume and Diagnostics Sales Forecast by Market SegmentItalyYersinia Test Volume and Diagnostics Sales Forecast by Market SegmentJapanCampylobacter Test Volume and Diagnostics Sales Forecast by Market SegmentJapanCampylobacter Diagnostics Sales by Major SupplierJapanCryptosporidium Test Volume and Diagnostics Sales Forecast by Market SegmentJapanCryptosporidium Diagnostics Sales by Major SupplierJapanE. Coli Test Volume and Diagnostics Sales Forecast by Market SegmentJapanEnterovirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapanRhinovirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapanRotavirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapanRotavirus Testing Market Diagnostics Sales by Major SupplierJapanSalmonella Test Volume and Diagnostics Sales Forecast by Market SegmentJapanShigella Test Volume and Diagnostics Sales Forecast by Market SegmentJapanShigella Testing Market Diagnostics Sales by Major SupplierJapanVibrio Test Volume and Diagnostics Sales Forecast by Market SegmentJapanYersinia Test Volume and Diagnostics Sales Forecast by Market SegmentSpainCampylobacter Test Volume and Diagnostics Sales Forecast by Market SegmentSpainCryptosporidium Test Volume and Diagnostics Sales Forecast by Market SegmentSpainE. Coli Test Volume and Diagnostics Sales Forecast by Market SegmentSpainEnterovirus Test Volume and Diagnostics Sales Forecast by Market SegmentSpainRhinovirus Test Volume and Diagnostics Sales Forecast by Market SegmentSpainRotavirus Test Volume and Diagnostics Sales Forecast by Market SegmentSpainRotavirus Testing Market Diagnostics Sales by Major SupplierSpainSalmonella Test Volume and Diagnostics Sales Forecast by Market SegmentSpainShigella Test Volume and Diagnostics Sales Forecast by Market SegmentSpainVibrio Test Volume and Diagnostics Sales Forecast by Market SegmentSpainYersinia Test Volume And Diagnostics Sales Forecast by Market SegmentU.K.Campylobacter Test Volume and Diagnostics Sales Forecast by Market SegmentU.K.Campylobacter Diagnostics Sales by Major SupplierU.K.Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market SegmentU.K.Cryptosporidium Diagnostics Sales by Major SupplierU.K.E. Coli Test Volume and Diagnostics Sales Forecast by Market SegmentU.K.Enterovirus Test Volume and Diagnostics Sales Forecast by Market SegmentU.K.Rhinovirus Test Volume and Diagnostics Sales Forecast by Market SegmentU.K.Rotavirus Test Volume and Diagnostics Sales Forecast by Market SegmentU.K.Rotavirus Testing Market Diagnostics Sales by Major SupplierU.K.Salmonella Test Volume and Diagnostics Sales Forecast by Market SegmentU.K.Shigella Test Volume and Diagnostics Sales Forecast by Market SegmentU.K.Shigella Testing Market Diagnostics Sales by Major SupplierU.K.Vibrio Test Volume and Diagnostics Sales Forecast by Market SegmentU.K.Yersinia Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Campylobacter Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Campylobacter Diagnostics Sales by Major SupplierU.S.A.Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Cryptosporidium Diagnostics Sales by Major SupplierU.S.A.E. Coli Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Enterovirus Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Enterovirus Testing Market Diagnostics Sales by Major SupplierU.S.A.Rhinovirus Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Rotavirus Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Rotavirus Testing Market Diagnostics Sales by Major SupplierU.S.A.Salmonella Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Salmonella Testing Market Diagnostics Sales by Major SupplierU.S.A.Shigella Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Shigella Testing Market Diagnostics Sales by Major SupplierU.S.A.Vibrio Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
To order this report: 2014 Opportunities in the Global Enteric Diseases Diagnostic Testing Market http://www.reportlinker.com/p01923220/2014-Opportunities-in-the-Global-Enteric-Diseases-Diagnostic-Testing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article